Cited by 484Computational Drug Discovery MethodsMachine Learning in Materials ScienceSynthesis and Characterization of Heterocyclic Compounds

Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?

Ajay, Walters, W. Patrick, Murcko, Mark A.·1998·Journal of Medicinal Chemistry

Abstract

We have used a Bayesian neural network to distinguish between drugs and nondrugs. For this purpose, the CMC acts as a surrogate for drug-like molecules while the ACD is a surrogate for nondrug-like molecules. This task is performed by using two different set of 1D and 2D parameters. The 1D parameters contain information about the entire molecule like the molecular weight and the the 2D parameters contain information about specific functional groups within the molecule. Our best results predict correctly on over 90% of the compounds in the CMC while classifying about 10% of the molecules in the ACD as drug-like. Excellent generalization ability is shown by the models in that roughly 80% of the molecules in the MDDR are classified as drug-like. We propose to use the models to design combinatorial libraries. In a computer experiment on generating a drug-like library of size 100 from a set of 10 000 molecules we obtain at least a 3 or 4 order of magnitude improvement over random methods. The neighborhoods defined by our models are not similar to the ones generated by standard Tanimoto similarity calculations. Therefore, new and different information is being generated by our models, and so it can supplement standard diversity approaches to library design.

Integrity signals

Registry

Crossref · 10.1021/jm970666c

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Machine learning models that discriminate 'drugs' from 'non-drugs' emerged in 1998, when scientists from Vertex and BASF independently proposed models to estimate 'drug-likeness,' showing that it is possible to train ML models based on chemical features to discriminate 'drugs' from 'non-drugs'.

    “Machine learning (ML) models that discriminate 'drugs' from 'non-drugs' emerged in 1998, when scientists from Vertex (27) and BASF (28) independently proposed models to estimate 'drug-likeness,' showing that it is possible to train ML models based on chemical features to discriminate 'drugs' (specifically, compounds that medicinal chemists have proposed for biological testing)”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ajay, Walters, W. P., & Murcko, M. A.
Affiliations
Vertex Pharmaceuticals (United States) (US)
Corresponding author
Ajay
Venue
Journal of Medicinal Chemistry
Published
1998-07-23
Volume
41
Issue
18
Pages
3314-3324
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2046564413
Cited by
484
References
21
Citations by year
2026: 6 · 2025: 9 · 2024: 9 · 2023: 11 · 2022: 8 · 2021: 8 · 2020: 14 · 2019: 6 · 2018: 10 · 2017: 9 · 2016: 6 · 2015: 13 · 2014: 13 · 2013: 10 · 2012: 13
FWCI
48.31
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
Keywords
drug-likeness prediction, Bayesian neural networks, molecular descriptors, 2D molecular descriptors, combinatorial library design, molecular diversity, Tanimoto similarity
MeSH terms
Bayes Theorem, Pharmaceutical Preparations, Drug Design, Databases, Factual, Neural Networks, Computer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review